NO20003273L - Substituerte <beta>-alaniner - Google Patents
Substituerte <beta>-alaninerInfo
- Publication number
- NO20003273L NO20003273L NO20003273A NO20003273A NO20003273L NO 20003273 L NO20003273 L NO 20003273L NO 20003273 A NO20003273 A NO 20003273A NO 20003273 A NO20003273 A NO 20003273A NO 20003273 L NO20003273 L NO 20003273L
- Authority
- NO
- Norway
- Prior art keywords
- beta
- compounds
- prodrugs
- halogen
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polyamides (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9727532.5A GB9727532D0 (en) | 1997-12-23 | 1997-12-23 | Chemical compounds |
US9260298P | 1998-07-13 | 1998-07-13 | |
PCT/GB1998/003859 WO1999033789A1 (en) | 1997-12-23 | 1998-12-23 | SUBSTITUTED β-ALANINES |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20003273D0 NO20003273D0 (no) | 2000-06-22 |
NO20003273L true NO20003273L (no) | 2000-06-22 |
Family
ID=26312873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003273A NO20003273L (no) | 1997-12-23 | 2000-06-22 | Substituerte <beta>-alaniner |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1042279B1 (no) |
JP (1) | JP4555469B2 (no) |
KR (1) | KR20010033520A (no) |
CN (1) | CN1163477C (no) |
AT (1) | ATE289991T1 (no) |
AU (1) | AU747907B2 (no) |
BR (1) | BR9814376A (no) |
CA (1) | CA2316235A1 (no) |
CZ (1) | CZ20002342A3 (no) |
DE (1) | DE69829215T2 (no) |
ES (1) | ES2235383T3 (no) |
HK (1) | HK1034508A1 (no) |
HU (1) | HUP0101701A3 (no) |
IL (1) | IL136584A (no) |
NO (1) | NO20003273L (no) |
NZ (1) | NZ505363A (no) |
SK (1) | SK9372000A3 (no) |
TR (1) | TR200001947T2 (no) |
WO (1) | WO1999033789A1 (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4564654B2 (ja) * | 1998-01-23 | 2010-10-20 | ノバルティス アーゲー | Vla−4アンタゴニスト |
AU1881900A (en) * | 1998-12-23 | 2000-07-31 | Aventis Pharma Limited | Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines |
BR0008280A (pt) * | 1999-02-18 | 2001-11-06 | Hoffmann La Roche | Derivados de tioamida |
NZ518886A (en) | 1999-12-28 | 2004-02-27 | Pfizer Prod Inc | Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
DE10019755A1 (de) * | 2000-04-20 | 2001-11-08 | Bayer Ag | Neue Aminoaryl/cycloalkylcarbonsäuren als Integrinantagonisten |
FR2812633A1 (fr) * | 2000-08-04 | 2002-02-08 | Aventis Cropscience Sa | Derives de phenyl(thio)urees et phenyl(thio)carbamates fongicides |
GB2367816A (en) | 2000-10-09 | 2002-04-17 | Bayer Ag | Urea- and thiourea-containing derivatives of beta-amino acids |
GB2369357A (en) * | 2000-10-09 | 2002-05-29 | Bayer Ag | Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
MXPA03003829A (es) | 2000-11-04 | 2003-07-28 | Aventis Pharma Ltd | Acidos alcanoicos substituidos. |
TWI312779B (no) | 2000-12-28 | 2009-08-01 | Daiichi Seiyaku Co | |
GB2377933A (en) | 2001-07-06 | 2003-01-29 | Bayer Ag | Succinic acid derivatives useful as integrin antagonists |
MXPA06000850A (es) | 2003-07-24 | 2006-03-30 | Daiichi Seiyaku Co | Compuesto de acido ciclohexancarboxilico. |
US20100261796A1 (en) * | 2005-04-28 | 2010-10-14 | Ferring B.V. | Use of Novel Compounds for IBD Treatment |
WO2007069635A1 (ja) | 2005-12-13 | 2007-06-21 | Daiichi Sankyo Company, Limited | Vla-4阻害薬 |
CA2714335A1 (en) | 2007-02-20 | 2008-08-28 | Merrimack Pharmaceuticals, Inc. | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
DE69613985T2 (de) * | 1995-08-30 | 2002-06-13 | G.D. Searle & Co., Chicago | Meta-guanidine, harnstoff, thioharnstoff oder azacyklische aminobenzoesäure-derivate als integrin antagonisten |
WO1997036859A1 (en) * | 1996-03-29 | 1997-10-09 | G.D. Searle & Co. | Para-substituted phenylpropanoic acid derivatives as integrin antagonists |
DE69706407T2 (de) * | 1996-03-29 | 2002-05-29 | G.D. Searle & Co., Chicago | META-SUBSTITUIERTE PHENYLENDERIVATE UND IHRE VERWENDUNG ALS ALPHAvBETA3 INTERGRIN-ANTAGONISTEN ODER INHIBITOREN |
PL340261A1 (en) * | 1997-10-31 | 2001-01-29 | Aventis Pharma Ltd | Substituted amilides |
-
1998
- 1998-12-23 HU HU0101701A patent/HUP0101701A3/hu unknown
- 1998-12-23 AT AT98962586T patent/ATE289991T1/de not_active IP Right Cessation
- 1998-12-23 ES ES98962586T patent/ES2235383T3/es not_active Expired - Lifetime
- 1998-12-23 AU AU17719/99A patent/AU747907B2/en not_active Ceased
- 1998-12-23 DE DE69829215T patent/DE69829215T2/de not_active Expired - Lifetime
- 1998-12-23 BR BR9814376-0A patent/BR9814376A/pt not_active Application Discontinuation
- 1998-12-23 CN CNB988125005A patent/CN1163477C/zh not_active Expired - Fee Related
- 1998-12-23 WO PCT/GB1998/003859 patent/WO1999033789A1/en active Search and Examination
- 1998-12-23 CA CA002316235A patent/CA2316235A1/en not_active Abandoned
- 1998-12-23 EP EP98962586A patent/EP1042279B1/en not_active Expired - Lifetime
- 1998-12-23 SK SK937-2000A patent/SK9372000A3/sk unknown
- 1998-12-23 NZ NZ505363A patent/NZ505363A/en unknown
- 1998-12-23 IL IL13658498A patent/IL136584A/xx not_active IP Right Cessation
- 1998-12-23 JP JP2000526473A patent/JP4555469B2/ja not_active Expired - Lifetime
- 1998-12-23 TR TR2000/01947T patent/TR200001947T2/xx unknown
- 1998-12-23 KR KR1020007007022A patent/KR20010033520A/ko not_active Application Discontinuation
- 1998-12-23 CZ CZ20002342A patent/CZ20002342A3/cs unknown
-
2000
- 2000-06-22 NO NO20003273A patent/NO20003273L/no not_active Application Discontinuation
-
2001
- 2001-07-27 HK HK01105254A patent/HK1034508A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU1771999A (en) | 1999-07-19 |
HUP0101701A3 (en) | 2003-02-28 |
HUP0101701A2 (hu) | 2001-11-28 |
NZ505363A (en) | 2005-02-25 |
DE69829215T2 (de) | 2005-07-21 |
CN1283181A (zh) | 2001-02-07 |
EP1042279A1 (en) | 2000-10-11 |
JP2001527061A (ja) | 2001-12-25 |
CA2316235A1 (en) | 1999-07-08 |
EP1042279B1 (en) | 2005-03-02 |
NO20003273D0 (no) | 2000-06-22 |
CN1163477C (zh) | 2004-08-25 |
DE69829215D1 (de) | 2005-04-07 |
BR9814376A (pt) | 2000-10-10 |
WO1999033789A1 (en) | 1999-07-08 |
HK1034508A1 (en) | 2001-10-26 |
IL136584A (en) | 2005-03-20 |
TR200001947T2 (tr) | 2001-01-22 |
ES2235383T3 (es) | 2005-07-01 |
CZ20002342A3 (cs) | 2001-11-14 |
IL136584A0 (en) | 2001-06-14 |
SK9372000A3 (en) | 2002-03-05 |
AU747907B2 (en) | 2002-05-30 |
KR20010033520A (ko) | 2001-04-25 |
JP4555469B2 (ja) | 2010-09-29 |
ATE289991T1 (de) | 2005-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE289991T1 (de) | Substituierte beta-alaninen | |
DK1027328T3 (da) | Substituerede anilider | |
DE69523169D1 (de) | Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung | |
TR200102959T2 (tr) | İntegrin antagonistleri olarak ikame edilmiş bisiklik heteroaril bileşikleri | |
HUP0204496A2 (en) | Novel piperidine compounds and pharmaceutical compositions containing the same and process for preparation the same | |
IT1295694B1 (it) | Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica | |
SE9604786D0 (sv) | New compounds | |
IL151172A0 (en) | Amine derivatives, their preparation and use as bax modulators | |
ATE270668T1 (de) | Phenoxypropanolamin-derivate, ihre herstellung und therapeutische verwendung | |
HU9603185D0 (en) | New azolidinediones as antihyperglycemic agents | |
FR2712591B1 (fr) | Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique. | |
CO4820432A1 (es) | Composiciones farmaceuticas para el tratamiento de rinitis que comprenden acido 2-(4-(difenilmetil)-1-piperacinil)-ace- tico o amida derivada y un compuesto seleccionado de pseudoe fedrina,fenilpropanolamina y fenilefrina | |
EE04308B1 (et) | Bensimidasooli ühendid, neid ühendeid sisaldavad farmatseutilised kompositsioonid ja nende kasutamine | |
ATE165368T1 (de) | Inhibitoren von testosteron-5-alpha reductase. | |
NO944892L (no) | N-substituerte 3-azabicyklo (3.2.0) hepatanderivater som neuroleptika osv. | |
DE69204041D1 (de) | Thiazolidinverbindeungen, deren Herstellung und therapeutische Verwendung. | |
HUP0102025A2 (hu) | Diaril-1,3,4-oxadiazolon-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
PT1068184E (pt) | Derivados n-ariloxietilamina para o tratamento de depressao | |
EP0638564A4 (en) | BENZOTHIAZOLESULFONAMIDE DERIVATIVE, PROCESS FOR PRODUCING THE SAME AND APPLICATION THEREOF. | |
NO950177D0 (no) | Farmakologisk aktive erivater | |
BR9808234A (pt) | Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas para a produção de uma composição farmacêutica para o tratamento de distúrbios do sono | |
MXPA02001861A (es) | Nuevos inhbidores de la integrina alfav beta3. | |
ATE203533T1 (de) | INDOLDERIVATE ALS PRODRUGS VON ß5-HT1-LIKEß REZEPTOR AGONISTEN | |
TR200402493T4 (tr) | Yeni 2,3-benzodiazepin türevleri ve aktif bileşen olarak bunları içeren farmasötik bileşimler. | |
BR9507668A (pt) | Intermédio para preparar um composto farmaceuticamente atívo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |